Combination lipid-lowering therapy, rather than high-intensity statin monotherapy, is proposed as a first-line standard of care to achieve LDL cholesterol goals in very high-risk patients.
Very high-risk atherosclerotic cardiovascular disease
Combination lipid-lowering therapy vs Statin monotherapy
Combination lipid-lowering therapy as first line strategy in very high-risk patients. Combination lipid-lowering therapy as first line strategy in very high-risk patients.
Building similarity graph...
Analyzing shared references across papers
Loading...
Kausik K. Ray
Laurens F. Reeskamp
Ulrich Laufs
European Heart Journal
Imperial College London
University of Amsterdam
University of Birmingham
Building similarity graph...
Analyzing shared references across papers
Loading...
Ray et al. (Thu,) conducted a editorial in Very high-risk atherosclerotic cardiovascular disease. Combination lipid-lowering therapy vs. Statin monotherapy was evaluated. Combination lipid-lowering therapy, rather than high-intensity statin monotherapy, is proposed as a first-line standard of care to achieve LDL cholesterol goals in very high-risk patients.
www.synapsesocial.com/papers/6a0726de2edded7c7b842aee — DOI: https://doi.org/10.1093/eurheartj/ehab718